X

Vous n'êtes pas connecté

Maroc Maroc - MOUNTAINTODAY.IN - A La Une - 11/Jul 18:28

Osteoarthritis Pipeline 2024 | Biosplice Therapeutics, Gilead Sciences, Flexion Therapeutics, GlaxoSmithKline, Levicept, Arthrogen, Personalized Stem Cells, Peptinov, Asahi Kasei Pharma

DelveInsight’s, “Osteoarthritis Pipeline Insight 2024” report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in the Osteoarthritis pipeline landscape. It covers the Osteoarthritis pipeline drug profiles, including Osteoarthritis clinical and nonclinical stage products. It

Articles similaires

Sorry! Image not available at this time

Adenoid Cystic Carcinoma Market to Grow at a Substantial Growth Rate During the Forecast Period | HLB, Ayala Pharma, Merck, Amgen, CureVac, Actuate Therapeutics

mountaintoday.in - 15/Aug 17:40

Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...

Sorry! Image not available at this time

Gilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

zacks.com - 08/Aug 22:00

The headline numbers for Gilead (GILD) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare...

Sorry! Image not available at this time

ZOLL announces successful bid to acquire ventilator business from Vyaire Medical

caribbeannewsglobal.com - 02:09

Completion of acquisition is subject to court approval and dependent on a successful closing CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL®, an Asahi...

Sorry! Image not available at this time

Royalty Pharma (RPRX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

zacks.com - 08/Aug 15:30

The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to...

Sorry! Image not available at this time

Will Ionis' (IONS) Wholly-Owned Drugs Drive Future Growth?

zacks.com - 15/Aug 13:15

Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the...

Sorry! Image not available at this time

Beam Therapeutics (BEAM) Q2 Earnings Beat, Revenues Miss

zacks.com - 07/Aug 14:50

Beam Therapeutics (BEAM) reports mixed second-quarter results. The company remains focused on pipeline development.

Breakthrough discovery could boost stem-cell transplants by improving cell mobilization

news.medical.net - 08/Aug 19:54

A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used...

Sorry! Image not available at this time

What causes of osteoarthritis in older people?

knowridge.com - 10/Aug 00:29

Osteoarthritis is a common condition that affects the joints, causing pain, stiffness, and reduced movement. It occurs when the protective cartilage...

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

news.medical.net - 12/Aug 17:15

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like...

Les derniers communiqués

  • Aucun élément